Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit-Reference-Cited by-同舟云学术

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit

Published:2021-05-01 Issue:3 Volume:29 Page:282-289
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomol Ther (Seoul)

Author:

Kandeel Mahmoud¹²,Yamamoto Mizuki³,Tani Hideki⁴,Kobayashi Ayako³,Gohda Jin³,Kawaguchi Yasushi³⁵,Park Byoung Kwon⁶,Kwon Hyung-Joo⁶,Inoue Jun-ichiro⁷,Alkattan Abdallah¹

Affiliation:

1. Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia

2. Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33516, Egypt

3. Research Center for Asian Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

4. Department of Virology, Toyama Institute of Health, Toyama 939-0363, Japan

5. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

6. Department of Microbiology, Hallym University College of Medicine, Chuncheon 24252, Republic of Korea

7. Senior Professor Office, The University of Tokyo, Tokyo 108-8639, Japan

Funder

Administration of International Cooperation and Knowledge Exchange (ICKEA), King Faisal University

Japanese Society for the Promotion of Science

Japan Initiative for Global Research Network on Infectious Diseases

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2021/029/BT2029-03-282.pdf

Reference44 articles.

1. Cell penetrating peptides as an innovative approach for drug delivery; then, present and the future

2. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

3. Predicting the Effect of Mutations on Protein-Protein Binding Interactions through Structure-Based Interface Profiles

4. Enfuvirtide−PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties

5. Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): In search of potent SARS-CoV entry inhibitors

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system;Crystallography Reviews;2024-07-11

2. Virus-mediated cell fusion of SARS-CoV-2 variants;Mathematical Biosciences;2024-03

3. Antiviral Protein–Protein Interaction Inhibitors;Journal of Medicinal Chemistry;2024-02-23

4. iDVEIP: A computer‐aided approach for the prediction of viral entry inhibitory peptides;PROTEOMICS;2024-01-23

5. Revolutionizing Healthcare: Harnessing the Power of Artificial Intelligence for Enhanced Diagnostics, Treatment and Drug Discovery;International Journal of Pharmacology;2024-01-15